TY - JOUR
T1 - A Phase 2 Study of Ianalumab in Patients with Primary Immune Thrombocytopenia Previously Treated with at Least Two Lines of Therapy
T2 - Interim Results from VAYHIT3
AU - Kuter, David J
AU - Gonzalez Lopez, Tomas Jose
AU - Trautmann-Grill, Karolin
AU - Rummel, Mathias J.
AU - Choi, Philip Young-Ill
AU - Borchiellini, Alessandra
AU - Ar, Muhlis Cem
AU - Tran, Huyen
AU - Zhu, Tienan
AU - Yoon, Jae-Ho
AU - Cooper, Nichola
AU - Stauch, Thomas
AU - Tarkun, Pinar
AU - Le Gac, Fabienne
AU - Allepuz, Alex
AU - Urban, Patrick
AU - Lin, Renxin
AU - Bradbury, Charlotte A.
PY - 2024/11/5
Y1 - 2024/11/5
U2 - 10.1182/blood-2024-201418
DO - 10.1182/blood-2024-201418
M3 - Article (Academic Journal)
SN - 0006-4971
VL - 144
SP - 710
JO - Blood
JF - Blood
IS - Supplement 1
ER -